Tessa Cigler

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Nancy Chan, Amy D. Willis, Naomi Kornhauser et al. · Clinical Cancer Research · 2016 · 225 citations

Medicine, Cancer Biology, Oncology +17

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

Denise A. Yardley, Robert Weaver, Michelle Melisko et al. · Journal of Clinical Oncology · 2015 · 189 citations · Full text

Medicine, Oncology, Pharmacology +17

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

Hope S. Rugo, Paula Klein, Susan A. Melin et al. · JAMA · 2017 · 184 citations

Medicine, Dermatology, Oncology +16

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i> - or <i>BRCA2</i> -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

George Somlo, Paul Frankel, Banu Arun et al. · Clinical Cancer Research · 2017 · 99 citations · Full text

Medicine, Oncology, Pharmacology +15

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer

Ying L. Liu, Cecilie L. Bager, Nicholas Willumsen et al. · npj Breast Cancer · 2021 · 97 citations · Full text

Medicine, Immunology, Oncology +17